| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |